A lot of the blockbuster products will lose their patents soon, so the companies are milking them for what it is worth. Of course everybody would rather have a young pipeline, but that is easier said than done. |
It makes sense because both Merck and Schering are too small to compete. |
It makes sense because both Merck and Schering are too small to compete. Sentiment is good for mergers and acquisitions at the moment. |
The basic problems of an empty pipeline and a difficult partner search remain. |
The dividend is a clear disappointment, that's a negative signal. Operating profit was also disappointing. They paid more for marketing and research and development than we anticipated. |
The pressure for consolidation is unavoidable and has gained new momentum. |
The share price can only be explained by takeover speculation. |
This is the right market to access for an Indian company. The market is saturated with branded generics. You can build from scratch, but that takes forever. |